Seven Companies Set Terms as Calendar moves forward to February

NEW FILINGS

Company: Decibel Therapeutics, Inc.
Symbol: DBTX
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: They are a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for hearing and balance disorders, one of the largest areas of unmet need in medicine.
Underwriter(s): Citigroup, SVB Leerink, BMO Capital Markets, Barclays
Filed: 1-22-21
Listed Cash Raise: $75m

Company: Talis Biomedical Corporation
Symbol: TLIS
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: Talis aims to transform diagnostic testing by developing and commercializing innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases and other conditions at the point-of-care.
Underwriter(s): JP Morgan, BofA Securities, Piper Sandler
Co-Manager: BTIG
Filed: 1-22-21
Listed Cash Raise: $150m

Company: AFC Gamma, Inc.
Symbol: AFCG
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: AFC Gamma, Inc. is a commercial real estate finance company founded in July 2020 by a veteran team of investment professionals.
Underwriter(s): JMP Securities, Ladenburg Thalmann, Seaport Global
Co-Manager: Lake Street
Filed: 1-22-21
Listed Cash Raise: $115m

Terms Added

Company: Landos Biopharma, Inc.
Symbol: LABP
Shares: 6.25 million
Price Range: $15.00-$17.00
Market Cap: $588m-$$666m
Trade Date: Thursday, 2/4
Description: They are a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases that are the first to target new mechanisms of action, including the LANCL2, NLRX1 and PLXDC2 immunometabolic pathways.according to the CIC report.
Underwriter(s): JP Morgan, Jefferies, SVB Leerink
Co-Manager(s): Raymond James
Terms Added: 1-28-21

Company: Sana Biotechnology, Inc.
Symbol: SANA
Shares: 15 million
Price Range: $20.00-$23.00
Market Cap: $3.5b-$4.03b
Trade Date: Thursday, 2/4
Description: They have long-term aspirations are to be able to control or modify any gene in the body, to replace any cell that is damaged or missing, and to markedly improve access to cellular and gene-based medicines.
Underwriter(s): Morgan Stanley, Goldman Sachs, J.P. Morgan, BofA Securities
Terms Added: 1-28-21

Company: loan Depot, Inc.
Symbol: LDI
Shares: 15 million
Price Range: $19.00-$21.00
Market Cap: $6.2b-$6.8b
Trade Date: Thursday, 2/4
Description: LoanDepot is a leading technology-enabled U.S. consumer lending platform.
Underwriter(s): Goldman Sachs, BofA Securities, Credit Suisse, Morgan Stanley, Barclays, Citigroup, Jefferies, UBS Investment Bank
Co-Manager(s): JMP Securities, Nomura, Piper Sandler, Raymond James, William Blair
Filed: 1-27-21

Company: On24 Inc
Symbol: ONTF
Shares: 8.6 million
Price Range: $45.00-$50.00
Market Cap: $2.0b-$2.22b
Trade Date: Wednesday, 2/3
Description: They provide a leading, cloud-based digital experience platform that enables businesses to convert customer engagement into revenue through interactive webinar experiences, virtual event experiences and multimedia content experiences.
Underwriter(s): Goldman Sachs, JP Morgan, KeyBanc Capital
Terms Added: 1-25-21

Company: Atotech Limited
Symbol: ATC
Description: They are the leading global provider of specialty electroplating solutions delivering chemistry, equipment, and service for high-growth technology applications.
Shares: 34.1 million
Price Range: $19.00-$22.00
Market Cap: $3.5b-$4.0b
Trade Date: Thursday 2/4
Underwriter(s): Citigroup, Credit Suisse, BofA Securities, JP Morgan
Barclays, Deutsche Bank, Jefferies, RBC Capital Markets, UBS Investment Bank, Baird, BMO Capital Markets, HSBC
Co-Manager(s): TPG Capital, Mischler Financial Group
Terms Added: 1-25-21

Company: Telus International (Cda), Inc.
Symbol: TIXT
Shares: 33.3 million
Price Range: $23.00-$25.00
Market Cap: $6.1b-$6.7b
Trade Date: Wednesday, 2/3
Description: They are a leading digital customer experience innovator that designs, builds and delivers next-generation solutions for global and disruptive brands.
Underwriter(s): JP Morgan, Morgan Stanley, Barclays, BofA Securities, CIBC Capital, Citigroup, Credit Suisse, RBC Capital, Baird, BMO Capital
Co-Manager(s): Scotiabank, TD, Wells Fargo, William Blair, MUFG, National Bank of Canada Financial Markets
Terms Added: 1-25-21

Company: Evaxion Biotech A/S
Symbol: EVAX
Shares: 2.75 million
Price Range: $10.00-$12.00
Market Cap: $190m-$227m
Trade Date: Thursday, 2/4
Description: They are a clinical-stage AI-immunology™ platform company using our propri
etary artificial intelligence, or AI, technology, engineering expertise and drug development know-how to simulate the human immune system and generate predictive models to identify and develop novel immunotherapies for the treatment of various cancers, bacterial diseases and viral infections.
Underwriter(s): Oppenheimer
Co-Manager: Ladenburg Thalmann
Terms Added: 1-25-21